Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6K Sell
273
-26,206
-99% -$2.47M 0.01% 227
2026
Q1
$3.13M Buy
+26,479
New +$3.27M 1.52% 20
2025
Q1
Sell
-85
Closed -$13.8K 277
2024
Q4
$13.8K Buy
+85
New +$15.2K 0.01% 167

Other funds holding ZTS

Stance Capital's ZTS Position: Q2 2026 in Review

Stance Capital reduced its Zoetis (ZTS) stake by 99% in Q2 2026, selling an estimated $2.47M and leaving 273 shares worth $19.6K. The position accounts for 0.01% of the portfolio, ranked #227.

Stance Capital first reported a position in ZTS in Q4 2024 and has held it in 3 quarters since. The position peaked at $3.13M in Q1 2026. 1,430 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Stance Capital held 273 shares of Zoetis worth $19.6K as of Q2 2026.
  • Stance Capital sold 26,206 Zoetis shares in Q2 2026, an estimated $2.47M.
  • Zoetis made up 0.01% of Stance Capital's portfolio in Q2 2026, its #227 holding.
  • Stance Capital first reported a position in Zoetis in Q4 2024 and has held it in 3 quarters since.
  • Stance Capital's Zoetis position peaked at $3.13M in Q1 2026.
  • 1,430 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.